Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Income from Non-Controlling Interests (2020)

Historic Income from Non-Controlling Interests for Terns Pharmaceuticals (TERN) over the last 1 years, with Q3 2020 value amounting to -$156000.0.

  • Terns Pharmaceuticals' Income from Non-Controlling Interests changed N/A to -$156000.0 in Q3 2020 from the same period last year, while for Jun 2021 it was -$313000.0, marking a year-over-year change of. This contributed to the annual value of -$518000.0 for FY2020, which is N/A changed from last year.
  • Latest data reveals that Terns Pharmaceuticals reported Income from Non-Controlling Interests of -$156000.0 as of Q3 2020.
  • Terns Pharmaceuticals' Income from Non-Controlling Interests' 5-year high stood at -$156000.0 during Q3 2020, with a 5-year trough of -$205000.0 in Q1 2020.